ChloroquineV1, Istex, Corpus, bibRecord, 000304

Periodic synopsis on collagen vascular disease

Identifieur interne : 000304 ( Istex/Corpus ); précédent : 000303; suivant : 000305

Periodic synopsis on collagen vascular disease

Auteurs : Jeffrey P. Callen ; Thomas T. Provost ; Denny L. Tuffanelli

Source :

Journal of the American Academy of Dermatology [ 0190-9622 ] ; 1985.

RBID : ISTEX:C7B74D7B59BE2EA0152E41D720891200CFB0D5B2

English descriptors

Teeft :
- Acad dermatol, American academy, Arch dermatol, Arthritis rheum, Callen, Chronic cutaneous lupus erythematosus, Clin rheum, Corticosteroid, Cutaneous, Cutaneous disease, Dermatol, Dermatomyositis, Diagnostic criteria, Discoid, Discoid lupus erythematosus, Discoid lupus erythematosus lesions, Eosinophilic fasciitis, Erythematosus, Lesion, Lupus, Lupus erythematosus, Lupus erythematosus patients, Malignancy, Polymyositis, Poor prognosis, Renal, Renal disease, Renal involvement, Rheum, Scleroderma, Sclerosis, Subacute, Subacute cutaneous lupus erythematosus, Systemic, Systemic disease, Systemic lupus erythematosus, Systemic sclerosis.

Url:

https://api.istex.fr/ark:/67375/6H6-5TWXRVR8-T/fulltext.pdf

DOI: 10.1016/S0190-9622(85)80393-5

Links to Exploration step

ISTEX:C7B74D7B59BE2EA0152E41D720891200CFB0D5B2

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Periodic synopsis on collagen vascular disease</title>
<author><name sortKey="Callen, Jeffrey P" sort="Callen, Jeffrey P" uniqKey="Callen J" first="Jeffrey P." last="Callen">Jeffrey P. Callen</name>
<affiliation><mods:affiliation>Louisville, KY, USABaltimore, MD, USASan Francisco, CA, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Provost, Thomas T" sort="Provost, Thomas T" uniqKey="Provost T" first="Thomas T." last="Provost">Thomas T. Provost</name>
<affiliation><mods:affiliation>Louisville, KY, USABaltimore, MD, USASan Francisco, CA, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Tuffanelli, Denny L" sort="Tuffanelli, Denny L" uniqKey="Tuffanelli D" first="Denny L." last="Tuffanelli">Denny L. Tuffanelli</name>
<affiliation><mods:affiliation>Louisville, KY, USABaltimore, MD, USASan Francisco, CA, USA</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C7B74D7B59BE2EA0152E41D720891200CFB0D5B2</idno>
<date when="1985" year="1985">1985</date>
<idno type="doi">10.1016/S0190-9622(85)80393-5</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-5TWXRVR8-T/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000304</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000304</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Periodic synopsis on collagen vascular disease</title>
<author><name sortKey="Callen, Jeffrey P" sort="Callen, Jeffrey P" uniqKey="Callen J" first="Jeffrey P." last="Callen">Jeffrey P. Callen</name>
<affiliation><mods:affiliation>Louisville, KY, USABaltimore, MD, USASan Francisco, CA, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Provost, Thomas T" sort="Provost, Thomas T" uniqKey="Provost T" first="Thomas T." last="Provost">Thomas T. Provost</name>
<affiliation><mods:affiliation>Louisville, KY, USABaltimore, MD, USASan Francisco, CA, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Tuffanelli, Denny L" sort="Tuffanelli, Denny L" uniqKey="Tuffanelli D" first="Denny L." last="Tuffanelli">Denny L. Tuffanelli</name>
<affiliation><mods:affiliation>Louisville, KY, USABaltimore, MD, USASan Francisco, CA, USA</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Journal of the American Academy of Dermatology</title>
<title level="j" type="abbrev">YMJD</title>
<idno type="ISSN">0190-9622</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1985">1985</date>
<biblScope unit="volume">13</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="supplement">P1</biblScope>
<biblScope unit="page" from="809">809</biblScope>
<biblScope unit="page" to="816">816</biblScope>
</imprint>
<idno type="ISSN">0190-9622</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0190-9622</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acad dermatol</term>
<term>American academy</term>
<term>Arch dermatol</term>
<term>Arthritis rheum</term>
<term>Callen</term>
<term>Chronic cutaneous lupus erythematosus</term>
<term>Clin rheum</term>
<term>Corticosteroid</term>
<term>Cutaneous</term>
<term>Cutaneous disease</term>
<term>Dermatol</term>
<term>Dermatomyositis</term>
<term>Diagnostic criteria</term>
<term>Discoid</term>
<term>Discoid lupus erythematosus</term>
<term>Discoid lupus erythematosus lesions</term>
<term>Eosinophilic fasciitis</term>
<term>Erythematosus</term>
<term>Lesion</term>
<term>Lupus</term>
<term>Lupus erythematosus</term>
<term>Lupus erythematosus patients</term>
<term>Malignancy</term>
<term>Polymyositis</term>
<term>Poor prognosis</term>
<term>Renal</term>
<term>Renal disease</term>
<term>Renal involvement</term>
<term>Rheum</term>
<term>Scleroderma</term>
<term>Sclerosis</term>
<term>Subacute</term>
<term>Subacute cutaneous lupus erythematosus</term>
<term>Systemic</term>
<term>Systemic disease</term>
<term>Systemic lupus erythematosus</term>
<term>Systemic sclerosis</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<istex><corpusName>elsevier</corpusName>
<keywords><teeft><json:string>lupus</json:string>
<json:string>erythematosus</json:string>
<json:string>cutaneous</json:string>
<json:string>scleroderma</json:string>
<json:string>dermatomyositis</json:string>
<json:string>systemic lupus erythematosus</json:string>
<json:string>dermatol</json:string>
<json:string>callen</json:string>
<json:string>lupus erythematosus</json:string>
<json:string>subacute</json:string>
<json:string>subacute cutaneous lupus erythematosus</json:string>
<json:string>corticosteroid</json:string>
<json:string>discoid lupus erythematosus</json:string>
<json:string>systemic disease</json:string>
<json:string>discoid</json:string>
<json:string>systemic</json:string>
<json:string>arch dermatol</json:string>
<json:string>renal</json:string>
<json:string>lesion</json:string>
<json:string>rheum</json:string>
<json:string>polymyositis</json:string>
<json:string>american academy</json:string>
<json:string>renal disease</json:string>
<json:string>clin rheum</json:string>
<json:string>cutaneous disease</json:string>
<json:string>arthritis rheum</json:string>
<json:string>systemic sclerosis</json:string>
<json:string>sclerosis</json:string>
<json:string>malignancy</json:string>
<json:string>eosinophilic fasciitis</json:string>
<json:string>renal involvement</json:string>
<json:string>diagnostic criteria</json:string>
<json:string>lupus erythematosus patients</json:string>
<json:string>poor prognosis</json:string>
<json:string>discoid lupus erythematosus lesions</json:string>
<json:string>acad dermatol</json:string>
<json:string>chronic cutaneous lupus erythematosus</json:string>
</teeft>
</keywords>
<author><json:item><name>Jeffrey P. Callen M.D.</name>
<affiliations><json:string>Louisville, KY, USABaltimore, MD, USASan Francisco, CA, USA</json:string>
</affiliations>
</json:item>
<json:item><name>Thomas T. Provost M.D.</name>
<affiliations><json:string>Louisville, KY, USABaltimore, MD, USASan Francisco, CA, USA</json:string>
</affiliations>
</json:item>
<json:item><name>Denny L. Tuffanelli M.D.</name>
<affiliations><json:string>Louisville, KY, USABaltimore, MD, USASan Francisco, CA, USA</json:string>
</affiliations>
</json:item>
</author>
<articleId><json:string>80393</json:string>
</articleId>
<arkIstex>ark:/67375/6H6-5TWXRVR8-T</arkIstex>
<language><json:string>eng</json:string>
</language>
<originalGenre><json:string>Full-length article</json:string>
</originalGenre>
<qualityIndicators><refBibsNative>true</refBibsNative>
<abstractWordCount>1</abstractWordCount>
<abstractCharCount>0</abstractCharCount>
<keywordCount>0</keywordCount>
<score>4.675</score>
<pdfWordCount>2663</pdfWordCount>
<pdfCharCount>21537</pdfCharCount>
<pdfVersion>1.4</pdfVersion>
<pdfPageCount>8</pdfPageCount>
<pdfPageSize>597.6 x 842.4 pts</pdfPageSize>
</qualityIndicators>
<title>Periodic synopsis on collagen vascular disease</title>
<pii><json:string>S0190-9622(85)80393-5</json:string>
</pii>
<genre><json:string>research-article</json:string>
</genre>
<serie><title>no. 2. Excellent state of the art discussions of lupus erythematosus and dermatomyositis</title>
<language><json:string>unknown</json:string>
</language>
</serie>
<host><title>Journal of the American Academy of Dermatology</title>
<language><json:string>unknown</json:string>
</language>
<publicationDate>1985</publicationDate>
<issn><json:string>0190-9622</json:string>
</issn>
<pii><json:string>S0190-9622(05)X7077-3</json:string>
</pii>
<volume>13</volume>
<issue>5</issue>
<pages><first>809</first>
<last>816</last>
</pages>
<genre><json:string>journal</json:string>
</genre>
</host>
<namedEntities><unitex><date><json:string>1985</json:string>
</date>
<geogName></geogName>
<orgName><json:string>American Rheumatism Association B</json:string>
<json:string>American Academy of Dermatology C</json:string>
<json:string>American Academy of Dermatology</json:string>
<json:string>Department of Dermatology, The Johns Hopkins Medical Institution, Baltimore</json:string>
</orgName>
<orgName_funder></orgName_funder>
<orgName_provider></orgName_provider>
<persName><json:string>J. Callen</json:string>
<json:string>A. Cutaneous</json:string>
<json:string>A. Criteria</json:string>
<json:string>A. Scleroderma</json:string>
<json:string>A. Hypothyroidism</json:string>
<json:string>C. Myositis</json:string>
<json:string>Denny L. Tuffanelli</json:string>
<json:string>C. Classification</json:string>
<json:string>A. Pathogenesis</json:string>
<json:string>Patients</json:string>
<json:string>A. Developed</json:string>
<json:string>A. Lupus</json:string>
<json:string>Journal</json:string>
<json:string>B. Criteria</json:string>
<json:string>I. Chronic</json:string>
<json:string>B. Studies</json:string>
<json:string>Thomas T. Provost</json:string>
<json:string>Current</json:string>
<json:string>B. Use</json:string>
</persName>
<placeName><json:string>United States</json:string>
<json:string>Baltimore</json:string>
<json:string>San Francisco</json:string>
<json:string>MD</json:string>
<json:string>CA</json:string>
<json:string>Louisville</json:string>
<json:string>KY</json:string>
</placeName>
<ref_url></ref_url>
<ref_bibl><json:string>Callen et al</json:string>
<json:string>Bohan and Peter, 1976</json:string>
</ref_bibl>
<bibl></bibl>
</unitex>
</namedEntities>
<ark><json:string>ark:/67375/6H6-5TWXRVR8-T</json:string>
</ark>
<categories><wos><json:string>1 - science</json:string>
<json:string>2 - dermatology</json:string>
</wos>
<scienceMetrix><json:string>1 - health sciences</json:string>
<json:string>2 - clinical medicine</json:string>
<json:string>3 - dermatology & venereal diseases</json:string>
</scienceMetrix>
<scopus><json:string>1 - Health Sciences</json:string>
<json:string>2 - Medicine</json:string>
<json:string>3 - Dermatology</json:string>
</scopus>
</categories>
<publicationDate>1985</publicationDate>
<copyrightDate>1985</copyrightDate>
<doi><json:string>10.1016/S0190-9622(85)80393-5</json:string>
</doi>
<id>C7B74D7B59BE2EA0152E41D720891200CFB0D5B2</id>
<score>1</score>
<fulltext><json:item><extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/ark:/67375/6H6-5TWXRVR8-T/fulltext.pdf</uri>
</json:item>
<json:item><extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/ark:/67375/6H6-5TWXRVR8-T/bundle.zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/6H6-5TWXRVR8-T/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Periodic synopsis on collagen vascular disease</title>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher scheme="https://scientific-publisher.data.istex.fr">ELSEVIER</publisher>
<availability><licence><p>©1985 American Academy of Dermatology, Inc.</p>
</licence>
<p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-HKKZVM7B-M">elsevier</p>
</availability>
<date>1985</date>
</publicationStmt>
<notesStmt><note type="research-article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</note>
<note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
</notesStmt>
<sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Periodic synopsis on collagen vascular disease</title>
<author xml:id="author-0000"><persName><forename type="first">Jeffrey P.</forename>
<surname>Callen</surname>
</persName>
<roleName type="degree">M.D.</roleName>
<note type="biography">Reprint requests to: Dr. J. Callen, 310 East Broadway, Suite 200, Louisville, KY 40202.</note>
<affiliation>Reprint requests to: Dr. J. Callen, 310 East Broadway, Suite 200, Louisville, KY 40202.</affiliation>
<affiliation>Louisville, KY, USABaltimore, MD, USASan Francisco, CA, USA</affiliation>
</author>
<author xml:id="author-0001"><persName><forename type="first">Thomas T.</forename>
<surname>Provost</surname>
</persName>
<roleName type="degree">M.D.</roleName>
<note type="biography">Department of Dermatology, The Johns Hopkins Medical Institution, Baltimore.</note>
<affiliation>Department of Dermatology, The Johns Hopkins Medical Institution, Baltimore.</affiliation>
<affiliation>Louisville, KY, USABaltimore, MD, USASan Francisco, CA, USA</affiliation>
</author>
<author xml:id="author-0002"><persName><forename type="first">Denny L.</forename>
<surname>Tuffanelli</surname>
</persName>
<roleName type="degree">M.D.</roleName>
<note type="biography">450 Sutter St., San Francisco, CA 94108.</note>
<affiliation>450 Sutter St., San Francisco, CA 94108.</affiliation>
<affiliation>Louisville, KY, USABaltimore, MD, USASan Francisco, CA, USA</affiliation>
</author>
<idno type="istex">C7B74D7B59BE2EA0152E41D720891200CFB0D5B2</idno>
<idno type="ark">ark:/67375/6H6-5TWXRVR8-T</idno>
<idno type="DOI">10.1016/S0190-9622(85)80393-5</idno>
<idno type="PII">S0190-9622(85)80393-5</idno>
<idno type="article-id">80393</idno>
</analytic>
<monogr><title level="j">Journal of the American Academy of Dermatology</title>
<title level="j" type="abbrev">YMJD</title>
<idno type="pISSN">0190-9622</idno>
<idno type="PII">S0190-9622(05)X7077-3</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1985"></date>
<biblScope unit="volume">13</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="supplement">P1</biblScope>
<biblScope unit="page" from="809">809</biblScope>
<biblScope unit="page" to="816">816</biblScope>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><creation><date>1985</date>
</creation>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
<revisionDesc><change when="1985">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/ark:/67375/6H6-5TWXRVR8-T/fulltext.txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="Elsevier doc found" wicri:toSee="Elsevier, no converted or simple article"><istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//ES//DTD journal article DTD version 5.0.1//EN//XML" URI="art501.dtd" name="istex:docType"></istex:docType>
<istex:document><article version="5.0" xml:lang="en" docsubtype="fla"><item-info><jid>YMJD</jid>
<aid>80393</aid>
<ce:pii>S0190-9622(85)80393-5</ce:pii>
<ce:doi>10.1016/S0190-9622(85)80393-5</ce:doi>
<ce:copyright type="unknown" year="1985">American Academy of Dermatology, Inc.</ce:copyright>
</item-info>
<head><ce:title>Periodic synopsis on collagen vascular disease</ce:title>
<ce:author-group><ce:author><ce:given-name>Jeffrey P.</ce:given-name>
<ce:surname>Callen</ce:surname>
<ce:degrees>M.D.</ce:degrees>
<ce:cross-ref refid="cor1"><ce:sup>‡</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author><ce:given-name>Thomas T.</ce:given-name>
<ce:surname>Provost</ce:surname>
<ce:degrees>M.D.</ce:degrees>
<ce:cross-ref refid="fn1"><ce:sup>*</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author><ce:given-name>Denny L.</ce:given-name>
<ce:surname>Tuffanelli</ce:surname>
<ce:degrees>M.D.</ce:degrees>
<ce:cross-ref refid="fn2"><ce:sup>**</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:affiliation id="aff1"><ce:label>a</ce:label>
<ce:textfn>Louisville, KY, USA</ce:textfn>
</ce:affiliation>
<ce:affiliation id="aff2"><ce:label>b</ce:label>
<ce:textfn>Baltimore, MD, USA</ce:textfn>
</ce:affiliation>
<ce:affiliation id="aff3"><ce:label>c</ce:label>
<ce:textfn>San Francisco, CA, USA</ce:textfn>
</ce:affiliation>
<ce:correspondence id="cor1"><ce:label>‡</ce:label>
<ce:text>Reprint requests to: Dr. J. Callen, 310 East Broadway, Suite 200, Louisville, KY 40202.</ce:text>
</ce:correspondence>
<ce:footnote id="fn1"><ce:label>*</ce:label>
<ce:note-para>Department of Dermatology, The Johns Hopkins Medical Institution, Baltimore.</ce:note-para>
</ce:footnote>
<ce:footnote id="fn2"><ce:label>**</ce:label>
<ce:note-para>450 Sutter St., San Francisco, CA 94108.</ce:note-para>
</ce:footnote>
</ce:author-group>
</head>
<tail><ce:bibliography><ce:section-title>References, General A. Books</ce:section-title>
<ce:bibliography-sec><ce:bib-reference id="bib1"><ce:label>1.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>IM</ce:given-name>
<ce:surname>Braverman</ce:surname>
</sb:author>
</sb:authors>
</sb:contribution>
<sb:host><sb:edited-book><sb:title><sb:maintitle>Skin signs of systemic disease</sb:maintitle>
</sb:title>
<sb:date>1981</sb:date>
<sb:publisher><sb:name>W. B. Saunders Co.</sb:name>
<sb:location>Philadelphia</sb:location>
</sb:publisher>
</sb:edited-book>
<sb:pages><sb:first-page>255</sb:first-page>
<sb:last-page>377</sb:last-page>
</sb:pages>
</sb:host>
<sb:comment>Excellent discussions of clinical descriptions, differential diagnosis, and presumed pathogenesis. The illustrations provided are a good adjunct to the text. Classification is not stressed. Therapy is not discussed</sb:comment>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib2"><ce:label>2.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>JP</ce:given-name>
<ce:surname>Callen</ce:surname>
</sb:author>
</sb:authors>
</sb:contribution>
<sb:host><sb:edited-book><sb:title><sb:maintitle>Cutaneous aspects of internal diseases</sb:maintitle>
</sb:title>
<sb:date>1981</sb:date>
<sb:publisher><sb:name>Year Book Medical Publishers, Inc.</sb:name>
<sb:location>Chicago</sb:location>
</sb:publisher>
</sb:edited-book>
<sb:pages><sb:first-page>3</sb:first-page>
<sb:last-page>60</sb:last-page>
</sb:pages>
</sb:host>
<sb:comment>In-depth discussion of clinical manifestations and their relationship to systemic disease. Management briefly discussed</sb:comment>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib3"><ce:label>3.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>JP</ce:given-name>
<ce:surname>Callen</ce:surname>
</sb:author>
</sb:authors>
</sb:contribution>
<sb:host><sb:edited-book><sb:book-series><sb:series><sb:title><sb:maintitle>Clinics in rheumatic disease</sb:maintitle>
</sb:title>
<sb:volume-nr>vol. 8</sb:volume-nr>
</sb:series>
</sb:book-series>
<sb:date>1982</sb:date>
<sb:publisher><sb:name>W. B. Saunders Co.</sb:name>
<sb:location>Philadelphia</sb:location>
</sb:publisher>
</sb:edited-book>
</sb:host>
<sb:comment>no. 2. Excellent state of the art discussions of lupus erythematosus and dermatomyositis</sb:comment>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib4"><ce:label>4.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D</ce:given-name>
<ce:surname>Tuffanelli</ce:surname>
</sb:author>
<sb:author><ce:given-name>N</ce:given-name>
<ce:surname>Rowell</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Collagen vascular diseases</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Semin Dermatol</sb:maintitle>
</sb:title>
<sb:volume-nr>June</sb:volume-nr>
</sb:series>
<sb:date>1985</sb:date>
</sb:issue>
</sb:host>
<sb:comment>Excellent state of the art discussions of lupus erythematosus and dermatomyositis</sb:comment>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib5"><ce:label>5.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>JP</ce:given-name>
<ce:surname>Callen</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Collagen vascular diseases</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Dermatologie Clinics</sb:maintitle>
</sb:title>
<sb:volume-nr>vol. 1</sb:volume-nr>
</sb:series>
<sb:issue-nr>no. 1</sb:issue-nr>
<sb:date>October, 1983</sb:date>
</sb:issue>
</sb:host>
<sb:comment>Very good reviews of collagen vascular disorders</sb:comment>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib6"><ce:label>6.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>GP</ce:given-name>
<ce:surname>Rodnan</ce:surname>
</sb:author>
<sb:author><ce:given-name>HR</ce:given-name>
<ce:surname>Schumacher</ce:surname>
</sb:author>
<sb:author><ce:given-name>NJ</ce:given-name>
<ce:surname>Zvaifler</ce:surname>
</sb:author>
</sb:authors>
</sb:contribution>
<sb:host><sb:edited-book><sb:title><sb:maintitle>Primer on rheumatic diseases</sb:maintitle>
</sb:title>
<sb:edition>ed. 8</sb:edition>
<sb:date>1983</sb:date>
<sb:publisher><sb:name>Arthritis Foundation</sb:name>
<sb:location>Atlanta, GA</sb:location>
</sb:publisher>
</sb:edited-book>
</sb:host>
</sb:reference>
</ce:bib-reference>
</ce:bibliography-sec>
<ce:bibliography-sec><ce:section-title>Lupus erythematosus Textbooks</ce:section-title>
<ce:bib-reference id="bib7"><ce:label>1.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>PH</ce:given-name>
<ce:surname>Schur</ce:surname>
</sb:author>
</sb:authors>
</sb:contribution>
<sb:host><sb:book><sb:title><sb:maintitle>The clinical management of systemic lupus erythematosus</sb:maintitle>
</sb:title>
<sb:date>1983</sb:date>
<sb:publisher><sb:name>Grune & Stratton, Inc.</sb:name>
<sb:location>New York</sb:location>
</sb:publisher>
</sb:book>
</sb:host>
<sb:comment>Excellent review of total subject with emphasis on systemic disease, but a good overall approach to patient. Sections by well-recognized authorities</sb:comment>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib8"><ce:label>2.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>JF</ce:given-name>
<ce:surname>Fries</ce:surname>
</sb:author>
<sb:author><ce:given-name>HR</ce:given-name>
<ce:surname>Holman</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Systemic lupus erythematosus: A clinical approach</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:edited-book><sb:book-series><sb:series><sb:title><sb:maintitle>Major problems in internal medicine</sb:maintitle>
</sb:title>
<sb:volume-nr>vol. 6</sb:volume-nr>
</sb:series>
</sb:book-series>
<sb:date>1975</sb:date>
<sb:publisher><sb:name>W. B. Saunders Co.</sb:name>
<sb:location>Philadelphia</sb:location>
</sb:publisher>
</sb:edited-book>
<sb:pages><sb:first-page>1</sb:first-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
</ce:bibliography-sec>
<ce:bibliography-sec><ce:section-title>Journal articles</ce:section-title>
<ce:bib-reference id="bib9"><ce:label>1.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>JP</ce:given-name>
<ce:surname>Callen</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Chronic cutaneous lupus erythematous</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arch Dermatol</sb:maintitle>
</sb:title>
<sb:volume-nr>118</sb:volume-nr>
</sb:series>
<sb:date>1982</sb:date>
</sb:issue>
<sb:pages><sb:first-page>412</sb:first-page>
<sb:last-page>416</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib10"><ce:label>2.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>SD</ce:given-name>
<ce:surname>Prystowsky</ce:surname>
</sb:author>
<sb:author><ce:given-name>JH</ce:given-name>
<ce:surname>Herndon</ce:surname>
</sb:author>
<sb:author><ce:given-name>JN</ce:given-name>
<ce:surname>Gilliam</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Chronic cutaneous lupus erythematosus (DLE)</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Medicine</sb:maintitle>
</sb:title>
<sb:volume-nr>55</sb:volume-nr>
</sb:series>
<sb:date>1976</sb:date>
</sb:issue>
<sb:pages><sb:first-page>183</sb:first-page>
<sb:last-page>191</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib11"><ce:label>3.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>LG</ce:given-name>
<ce:surname>Millard</ce:surname>
</sb:author>
<sb:author><ce:given-name>NR</ce:given-name>
<ce:surname>Rowell</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Abnormal laboratory test results and their relationship to prognosis in discoid lupus erythematosus</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arch Dermatol</sb:maintitle>
</sb:title>
<sb:volume-nr>115</sb:volume-nr>
</sb:series>
<sb:date>1979</sb:date>
</sb:issue>
<sb:pages><sb:first-page>1055</sb:first-page>
<sb:last-page>1058</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib12"><ce:label>4.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>RD</ce:given-name>
<ce:surname>Sontheimer</ce:surname>
</sb:author>
<sb:author><ce:given-name>JR</ce:given-name>
<ce:surname>Thomas</ce:surname>
</sb:author>
<sb:author><ce:given-name>JN</ce:given-name>
<ce:surname>Gilliam</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Subacute cutaneous lupus erythematosus</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arch Dermatol</sb:maintitle>
</sb:title>
<sb:volume-nr>115</sb:volume-nr>
</sb:series>
<sb:date>1979</sb:date>
</sb:issue>
<sb:pages><sb:first-page>1409</sb:first-page>
<sb:last-page>1415</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib13"><ce:label>5.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>J</ce:given-name>
<ce:surname>Uitto</ce:surname>
</sb:author>
<sb:author><ce:given-name>DJ</ce:given-name>
<ce:surname>Santa-Cruz</ce:surname>
</sb:author>
<sb:author><ce:given-name>AZ</ce:given-name>
<ce:surname>Eisen</ce:surname>
</sb:author>
<sb:et-al></sb:et-al>
</sb:authors>
<sb:title><sb:maintitle>Verrucous lesions in patients with discoid lupus erythematosus</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Br J Dermatol</sb:maintitle>
</sb:title>
<sb:volume-nr>98</sb:volume-nr>
</sb:series>
<sb:date>1978</sb:date>
</sb:issue>
<sb:pages><sb:first-page>507</sb:first-page>
<sb:last-page>520</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib14"><ce:label>6.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>EM</ce:given-name>
<ce:surname>Tan</ce:surname>
</sb:author>
<sb:author><ce:given-name>AS</ce:given-name>
<ce:surname>Cohen</ce:surname>
</sb:author>
<sb:author><ce:given-name>JF</ce:given-name>
<ce:surname>Fries</ce:surname>
</sb:author>
<sb:et-al></sb:et-al>
</sb:authors>
<sb:title><sb:maintitle>The 1982 revised criteria for the classification of systemic lupus erythematosus</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arthritis Rheum</sb:maintitle>
</sb:title>
<sb:volume-nr>25</sb:volume-nr>
</sb:series>
<sb:date>1982</sb:date>
</sb:issue>
<sb:pages><sb:first-page>1271</sb:first-page>
<sb:last-page>1277</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib15"><ce:label>7.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>TT</ce:given-name>
<ce:surname>Provost</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Subsets in systemic lupus erythematosus</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Invest Dermatol</sb:maintitle>
</sb:title>
<sb:volume-nr>72</sb:volume-nr>
</sb:series>
<sb:date>1979</sb:date>
</sb:issue>
<sb:pages><sb:first-page>110</sb:first-page>
<sb:last-page>113</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib16"><ce:label>8.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>PR</ce:given-name>
<ce:surname>Vandersteen</ce:surname>
</sb:author>
<sb:author><ce:given-name>TT</ce:given-name>
<ce:surname>Provost</ce:surname>
</sb:author>
<sb:author><ce:given-name>RE</ce:given-name>
<ce:surname>Jordon</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>C2 deficient systemic lupus erythematosus: The association with anti-Ro (SSA) antibodies</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arch Dermatol</sb:maintitle>
</sb:title>
<sb:volume-nr>118</sb:volume-nr>
</sb:series>
<sb:date>1982</sb:date>
</sb:issue>
<sb:pages><sb:first-page>584</sb:first-page>
<sb:last-page>587</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib17"><ce:label>9.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>RD</ce:given-name>
<ce:surname>Sontheimer</ce:surname>
</sb:author>
<sb:author><ce:given-name>PJ</ce:given-name>
<ce:surname>Maddison</ce:surname>
</sb:author>
<sb:author><ce:given-name>M</ce:given-name>
<ce:surname>Reichlin</ce:surname>
</sb:author>
<sb:et-al></sb:et-al>
</sb:authors>
<sb:title><sb:maintitle>Serological and HLA association in subacute cutaneous lupus erythematosus</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Ann Intern Med</sb:maintitle>
</sb:title>
<sb:volume-nr>97</sb:volume-nr>
</sb:series>
<sb:date>1982</sb:date>
</sb:issue>
<sb:pages><sb:first-page>664</sb:first-page>
<sb:last-page>671</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib18"><ce:label>10.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>DL</ce:given-name>
<ce:surname>Tuffanelli</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Lupus erythematosus</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Am Acad Dermatol</sb:maintitle>
</sb:title>
<sb:volume-nr>4</sb:volume-nr>
</sb:series>
<sb:date>1981</sb:date>
</sb:issue>
<sb:pages><sb:first-page>127</sb:first-page>
<sb:last-page>142</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib19"><ce:label>11.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>RD</ce:given-name>
<ce:surname>Sontheimer</ce:surname>
</sb:author>
<sb:author><ce:given-name>J-S</ce:given-name>
<ce:surname>Deng</ce:surname>
</sb:author>
<sb:author><ce:given-name>JN</ce:given-name>
<ce:surname>Gilliam</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Antinuclear and anticytoplasmic antibodies</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Am Acad Dermatol</sb:maintitle>
</sb:title>
<sb:volume-nr>9</sb:volume-nr>
</sb:series>
<sb:date>1983</sb:date>
</sb:issue>
<sb:pages><sb:first-page>335</sb:first-page>
<sb:last-page>343</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib20"><ce:label>12.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>LA</ce:given-name>
<ce:surname>Lee</ce:surname>
</sb:author>
<sb:author><ce:given-name>WB</ce:given-name>
<ce:surname>Bias</ce:surname>
</sb:author>
<sb:author><ce:given-name>FC</ce:given-name>
<ce:surname>Arnett</ce:surname>
</sb:author>
<sb:et-al></sb:et-al>
</sb:authors>
<sb:title><sb:maintitle>Immunogenetics of the neonatal lupus syndrome</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Ann Intern Med</sb:maintitle>
</sb:title>
<sb:volume-nr>99</sb:volume-nr>
</sb:series>
<sb:date>1983</sb:date>
</sb:issue>
<sb:pages><sb:first-page>592</sb:first-page>
<sb:last-page>596</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib21"><ce:label>13.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>MB</ce:given-name>
<ce:surname>Stevens</ce:surname>
</sb:author>
<sb:author><ce:given-name>BH</ce:given-name>
<ce:surname>Hahn</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Management of systemic lupus erythematosus</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Bull Rheum Dis</sb:maintitle>
</sb:title>
<sb:volume-nr>32</sb:volume-nr>
</sb:series>
<sb:date>1982</sb:date>
</sb:issue>
<sb:pages><sb:first-page>35</sb:first-page>
<sb:last-page>42</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib22"><ce:label>14.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>GRV</ce:given-name>
<ce:surname>Hughes</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Lupus erythematosus</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Clin Rheum Dis</sb:maintitle>
</sb:title>
<sb:volume-nr>8</sb:volume-nr>
</sb:series>
<sb:issue-nr>1</sb:issue-nr>
<sb:date>1983</sb:date>
</sb:issue>
</sb:host>
</sb:reference>
</ce:bib-reference>
</ce:bibliography-sec>
<ce:bibliography-sec><ce:section-title>Dermatomyositis Journal articles</ce:section-title>
<ce:bib-reference id="bib23"><ce:label>1.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>JP</ce:given-name>
<ce:surname>Callen</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Dermatomyositis: An update 1985</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Semin Dermatol</sb:maintitle>
</sb:title>
<sb:volume-nr>4</sb:volume-nr>
</sb:series>
<sb:date>1985</sb:date>
</sb:issue>
<sb:pages><sb:first-page>114</sb:first-page>
<sb:last-page>125</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib24"><ce:label>2.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>A</ce:given-name>
<ce:surname>Bohan</ce:surname>
</sb:author>
<sb:author><ce:given-name>JB</ce:given-name>
<ce:surname>Peter</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Polymyositis and dermatomyositis</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>N Engl J Med</sb:maintitle>
</sb:title>
<sb:volume-nr>292</sb:volume-nr>
</sb:series>
<sb:date>1976</sb:date>
</sb:issue>
<sb:pages><sb:first-page>344</sb:first-page>
<sb:last-page>403</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib25"><ce:label>3.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>JP</ce:given-name>
<ce:surname>Callen</ce:surname>
</sb:author>
<sb:author><ce:given-name>JJ</ce:given-name>
<ce:surname>Hyla</ce:surname>
</sb:author>
<sb:author><ce:given-name>GG</ce:given-name>
<ce:surname>Bole</ce:surname>
</sb:author>
<sb:author><ce:given-name>D</ce:given-name>
<ce:surname>Kay</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>The relationship of dermatomyositis and polymyositis to internal malignancy</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arch Dermatol</sb:maintitle>
</sb:title>
<sb:volume-nr>116</sb:volume-nr>
</sb:series>
<sb:date>1980</sb:date>
</sb:issue>
<sb:pages><sb:first-page>295</sb:first-page>
<sb:last-page>298</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib26"><ce:label>4.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>PC</ce:given-name>
<ce:surname>Dau</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Plasmapheresis in idiopathic inflammatory myopathy</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arch Neurol</sb:maintitle>
</sb:title>
<sb:volume-nr>38</sb:volume-nr>
</sb:series>
<sb:date>1981</sb:date>
</sb:issue>
<sb:pages><sb:first-page>544</sb:first-page>
<sb:last-page>547</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib27"><ce:label>5.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>LP</ce:given-name>
<ce:surname>Rowland</ce:surname>
</sb:author>
<sb:author><ce:given-name>C</ce:given-name>
<ce:surname>Clark</ce:surname>
</sb:author>
<sb:author><ce:given-name>M</ce:given-name>
<ce:surname>Olarte</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Therapy of dermatomyositis</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Adv Neurol</sb:maintitle>
</sb:title>
<sb:volume-nr>17</sb:volume-nr>
</sb:series>
<sb:date>1977</sb:date>
</sb:issue>
<sb:pages><sb:first-page>63</sb:first-page>
<sb:last-page>97</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib28"><ce:label>6.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>RK</ce:given-name>
<ce:surname>Winkelmann</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Dermatomyositis in childhood</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Clin Rheum Dis</sb:maintitle>
</sb:title>
<sb:volume-nr>8</sb:volume-nr>
</sb:series>
<sb:date>1982</sb:date>
</sb:issue>
<sb:pages><sb:first-page>353</sb:first-page>
<sb:last-page>368</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib29"><ce:label>7.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>TY</ce:given-name>
<ce:surname>Woo</ce:surname>
</sb:author>
<sb:author><ce:given-name>JP</ce:given-name>
<ce:surname>Callen</ce:surname>
</sb:author>
<sb:author><ce:given-name>JJ</ce:given-name>
<ce:surname>Voorhees</ce:surname>
</sb:author>
<sb:et-al></sb:et-al>
</sb:authors>
<sb:title><sb:maintitle>Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Am Acad Dermatol</sb:maintitle>
</sb:title>
<sb:volume-nr>10</sb:volume-nr>
</sb:series>
<sb:date>1984</sb:date>
</sb:issue>
<sb:pages><sb:first-page>592</sb:first-page>
<sb:last-page>600</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib30"><ce:label>8.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>BM</ce:given-name>
<ce:surname>Ansell</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Inflammatory disorders of muscles</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Clin Rheum Dis</sb:maintitle>
</sb:title>
<sb:volume-nr>10</sb:volume-nr>
</sb:series>
<sb:date>1984</sb:date>
</sb:issue>
<sb:pages><sb:first-page>1</sb:first-page>
<sb:last-page>216</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
</ce:bibliography-sec>
<ce:bibliography-sec><ce:section-title>Scleroderma Textbook</ce:section-title>
<ce:bib-reference id="bib31"><ce:label>1.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>S</ce:given-name>
<ce:surname>Jablonska</ce:surname>
</sb:author>
</sb:authors>
</sb:contribution>
<sb:host><sb:book><sb:title><sb:maintitle>Scleroderma and pseudoscleroderma</sb:maintitle>
</sb:title>
<sb:edition>ed. 2</sb:edition>
<sb:date>1975</sb:date>
<sb:publisher><sb:name>Polish Medical Publishers</sb:name>
<sb:location>Warsaw</sb:location>
</sb:publisher>
</sb:book>
</sb:host>
<sb:comment>Extensive review of scleroderma and related phenomenon. Well-referenced</sb:comment>
</sb:reference>
</ce:bib-reference>
</ce:bibliography-sec>
<ce:bibliography-sec><ce:section-title>Journal articles</ce:section-title>
<ce:bib-reference id="bib32"><ce:label>1.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:collaboration>ARA subcommittee for scleroderma criteria</sb:collaboration>
</sb:authors>
<sb:title><sb:maintitle>Preliminary criteria for the classification of systemic sclerosis (scleroderma)</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arthritis Rheum</sb:maintitle>
</sb:title>
</sb:series>
<sb:date>1980</sb:date>
</sb:issue>
<sb:pages><sb:first-page>581</sb:first-page>
<sb:last-page>590</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib33"><ce:label>2.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>MC</ce:given-name>
<ce:surname>Hochberg</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>The spectrum of systemic sclerosis—current concepts</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Hosp Pract</sb:maintitle>
</sb:title>
<sb:volume-nr>16</sb:volume-nr>
</sb:series>
<sb:date>1981</sb:date>
</sb:issue>
<sb:pages><sb:first-page>61</sb:first-page>
<sb:last-page>72</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib34"><ce:label>3.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>RC</ce:given-name>
<ce:surname>Siegel</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Scleroderma</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Med Clin North Am</sb:maintitle>
</sb:title>
<sb:volume-nr>61</sb:volume-nr>
</sb:series>
<sb:date>1977</sb:date>
</sb:issue>
<sb:pages><sb:first-page>283</sb:first-page>
<sb:last-page>297</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib35"><ce:label>4.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>EC</ce:given-name>
<ce:surname>Leroy</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Pathogenesis of scleroderma (systemic sclerosis)</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Invest Dermatol</sb:maintitle>
</sb:title>
<sb:volume-nr>79</sb:volume-nr>
</sb:series>
<sb:issue-nr>suppl 1</sb:issue-nr>
<sb:date>1982</sb:date>
</sb:issue>
<sb:pages><sb:first-page>87s</sb:first-page>
<sb:last-page>89s</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib36"><ce:label>5.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>EM</ce:given-name>
<ce:surname>Tan</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Antinuclear antibodies in scleroderma</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Int J Dermatol</sb:maintitle>
</sb:title>
<sb:volume-nr>20</sb:volume-nr>
</sb:series>
<sb:date>1981</sb:date>
</sb:issue>
<sb:pages><sb:first-page>569</sb:first-page>
<sb:last-page>573</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib37"><ce:label>6.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>K</ce:given-name>
<ce:surname>Takehara</ce:surname>
</sb:author>
<sb:author><ce:given-name>Y</ce:given-name>
<ce:surname>Moroi</ce:surname>
</sb:author>
<sb:author><ce:given-name>Y</ce:given-name>
<ce:surname>Nakabayashi</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Antinuclear antibodies in localized scleroderma</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arthritis Rheum</sb:maintitle>
</sb:title>
<sb:volume-nr>26</sb:volume-nr>
</sb:series>
<sb:date>1983</sb:date>
</sb:issue>
<sb:pages><sb:first-page>612</sb:first-page>
<sb:last-page>616</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib38"><ce:label>7.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>CJ</ce:given-name>
<ce:surname>Michet</ce:surname>
</sb:author>
<sb:author><ce:given-name>JA</ce:given-name>
<ce:surname>Doyle</ce:surname>
</sb:author>
<sb:author><ce:given-name>WW</ce:given-name>
<ce:surname>Ginsburg</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Eosinophilic fasciitis</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mayo Clin Proc</sb:maintitle>
</sb:title>
<sb:volume-nr>56</sb:volume-nr>
</sb:series>
<sb:date>1981</sb:date>
</sb:issue>
<sb:pages><sb:first-page>27</sb:first-page>
<sb:last-page>34</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib39"><ce:label>8.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>SC</ce:given-name>
<ce:surname>Duncan</ce:surname>
</sb:author>
<sb:author><ce:given-name>RK</ce:given-name>
<ce:surname>Winkelmann</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Cancer and scleroderma</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arch Dermatol</sb:maintitle>
</sb:title>
<sb:volume-nr>115</sb:volume-nr>
</sb:series>
<sb:date>1979</sb:date>
</sb:issue>
<sb:pages><sb:first-page>950</sb:first-page>
<sb:last-page>955</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib40"><ce:label>9.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>VD</ce:given-name>
<ce:surname>Steen</ce:surname>
</sb:author>
<sb:author><ce:given-name>TA</ce:given-name>
<ce:surname>Medsger</ce:surname>
</sb:author>
<sb:author><ce:given-name>GP</ce:given-name>
<ce:surname>Rodnan</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle><ce:small-caps>d</ce:small-caps>
-Penicil-lamine therapy in progressive systemic sclerosis (scleroderma)</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Ann Intern Med</sb:maintitle>
</sb:title>
<sb:volume-nr>97</sb:volume-nr>
</sb:series>
<sb:date>1982</sb:date>
</sb:issue>
<sb:pages><sb:first-page>652</sb:first-page>
<sb:last-page>659</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib41"><ce:label>10.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>GT</ce:given-name>
<ce:surname>Jansen</ce:surname>
</sb:author>
<sb:author><ce:given-name>DF</ce:given-name>
<ce:surname>Barraza</ce:surname>
</sb:author>
<sb:author><ce:given-name>JL</ce:given-name>
<ce:surname>Ballard</ce:surname>
</sb:author>
<sb:et-al></sb:et-al>
</sb:authors>
<sb:title><sb:maintitle>Generalized scleroderma: Treatment with an immunosuppressive agent</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arch Dermatol</sb:maintitle>
</sb:title>
<sb:volume-nr>97</sb:volume-nr>
</sb:series>
<sb:date>1968</sb:date>
</sb:issue>
<sb:pages><sb:first-page>690</sb:first-page>
<sb:last-page>692</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib42"><ce:label>11.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D</ce:given-name>
<ce:surname>Alarcon-Segovia</ce:surname>
</sb:author>
<sb:author><ce:given-name>F</ce:given-name>
<ce:surname>Ramos-Niembro</ce:surname>
</sb:author>
<sb:author><ce:given-name>G</ce:given-name>
<ce:surname>Ibanez de Kasep</ce:surname>
</sb:author>
<sb:et-al></sb:et-al>
</sb:authors>
<sb:title><sb:maintitle>Long-term evaluation of colchicine in the treatment of scleroderma</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Rheumatol</sb:maintitle>
</sb:title>
<sb:volume-nr>6</sb:volume-nr>
</sb:series>
<sb:date>1979</sb:date>
</sb:issue>
<sb:pages><sb:first-page>705</sb:first-page>
<sb:last-page>712</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib43"><ce:label>12.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>RH</ce:given-name>
<ce:surname>Thurm</ce:surname>
</sb:author>
<sb:author><ce:given-name>JC</ce:given-name>
<ce:surname>Alexander</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Captopril in the treatment of sclerodermal renal crisis</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arch Intern Med</sb:maintitle>
</sb:title>
<sb:volume-nr>144</sb:volume-nr>
</sb:series>
<sb:date>1984</sb:date>
</sb:issue>
<sb:pages><sb:first-page>733</sb:first-page>
<sb:last-page>735</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib44"><ce:label>13.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>PC</ce:given-name>
<ce:surname>Dau</ce:surname>
</sb:author>
<sb:author><ce:given-name>MB</ce:given-name>
<ce:surname>Kahaleh</ce:surname>
</sb:author>
<sb:author><ce:given-name>RW</ce:given-name>
<ce:surname>Sagebiel</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Plasmapheresis and immunosuppressive drug therapy in scleroderma</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arthritis Rheum</sb:maintitle>
</sb:title>
<sb:volume-nr>24</sb:volume-nr>
</sb:series>
<sb:date>1981</sb:date>
</sb:issue>
<sb:pages><sb:first-page>1128</sb:first-page>
<sb:last-page>1135</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib45"><ce:label>14.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>M</ce:given-name>
<ce:surname>Peters-Golden</ce:surname>
</sb:author>
<sb:author><ce:given-name>RA</ce:given-name>
<ce:surname>Wise</ce:surname>
</sb:author>
<sb:author><ce:given-name>P</ce:given-name>
<ce:surname>Schneider</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Medicine</sb:maintitle>
</sb:title>
<sb:volume-nr>63</sb:volume-nr>
</sb:series>
<sb:date>1984</sb:date>
</sb:issue>
<sb:pages><sb:first-page>221</sb:first-page>
<sb:last-page>231</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib46"><ce:label>15.</ce:label>
<sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>GP</ce:given-name>
<ce:surname>Rodnan</ce:surname>
</sb:author>
</sb:authors>
<sb:title><sb:maintitle>Progressive systemic sclerosis</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Clin Rheum Dis</sb:maintitle>
</sb:title>
<sb:volume-nr>5</sb:volume-nr>
</sb:series>
<sb:date>1979</sb:date>
</sb:issue>
<sb:pages><sb:first-page>1</sb:first-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
</ce:bibliography-sec>
</ce:bibliography>
</tail>
</article>
</istex:document>
</istex:metadataXml>
<mods version="3.6"><titleInfo lang="en"><title>Periodic synopsis on collagen vascular disease</title>
</titleInfo>
<titleInfo type="alternative" lang="en" contentType="CDATA"><title>Periodic synopsis on collagen vascular disease</title>
</titleInfo>
<name type="personal"><namePart type="given">Jeffrey P.</namePart>
<namePart type="family">Callen</namePart>
<namePart type="termsOfAddress">M.D.</namePart>
<affiliation>Louisville, KY, USABaltimore, MD, USASan Francisco, CA, USA</affiliation>
<description>Reprint requests to: Dr. J. Callen, 310 East Broadway, Suite 200, Louisville, KY 40202.</description>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Thomas T.</namePart>
<namePart type="family">Provost</namePart>
<namePart type="termsOfAddress">M.D.</namePart>
<affiliation>Louisville, KY, USABaltimore, MD, USASan Francisco, CA, USA</affiliation>
<description>Department of Dermatology, The Johns Hopkins Medical Institution, Baltimore.</description>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Denny L.</namePart>
<namePart type="family">Tuffanelli</namePart>
<namePart type="termsOfAddress">M.D.</namePart>
<affiliation>Louisville, KY, USABaltimore, MD, USASan Francisco, CA, USA</affiliation>
<description>450 Sutter St., San Francisco, CA 94108.</description>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="research-article" displayLabel="Full-length article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre>
<originInfo><publisher>ELSEVIER</publisher>
<dateIssued encoding="w3cdtf">1985</dateIssued>
<copyrightDate encoding="w3cdtf">1985</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<relatedItem type="host"><titleInfo><title>Journal of the American Academy of Dermatology</title>
</titleInfo>
<titleInfo type="abbreviated"><title>YMJD</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<originInfo><publisher>ELSEVIER</publisher>
<dateIssued encoding="w3cdtf">1985</dateIssued>
</originInfo>
<identifier type="ISSN">0190-9622</identifier>
<identifier type="PII">S0190-9622(05)X7077-3</identifier>
<part><date>1985</date>
<detail type="volume"><number>13</number>
<caption>vol.</caption>
</detail>
<detail type="issue"><number>5</number>
<caption>no.</caption>
</detail>
<detail type="supplement"><number>P1</number>
<caption>Suppl.</caption>
</detail>
<extent unit="issue-pages"><start>701</start>
<end>864</end>
</extent>
<extent unit="pages"><start>809</start>
<end>816</end>
</extent>
</part>
</relatedItem>
<identifier type="istex">C7B74D7B59BE2EA0152E41D720891200CFB0D5B2</identifier>
<identifier type="ark">ark:/67375/6H6-5TWXRVR8-T</identifier>
<identifier type="DOI">10.1016/S0190-9622(85)80393-5</identifier>
<identifier type="PII">S0190-9622(85)80393-5</identifier>
<identifier type="ArticleID">80393</identifier>
<accessCondition type="use and reproduction" contentType="copyright">©1985 American Academy of Dermatology, Inc.</accessCondition>
<recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-HKKZVM7B-M">elsevier</recordContentSource>
<recordOrigin>American Academy of Dermatology, Inc., ©1985</recordOrigin>
</recordInfo>
</mods>
<json:item><extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/ark:/67375/6H6-5TWXRVR8-T/record.json</uri>
</json:item>
</metadata>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000304 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000304 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:C7B74D7B59BE2EA0152E41D720891200CFB0D5B2
   |texte=   Periodic synopsis on collagen vascular disease
}}

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021

	Serveur d'exploration Chloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Chloroquine

Periodic synopsis on collagen vascular disease

Periodic synopsis on collagen vascular disease

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri